ClinicalTrials.Veeva

Menu
R

Revmatologie s.r.o. | Brno, Czech Republic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apremilast
Tofacitinib
IPP-201101
Olokizumab
BIIB059
Litifilimab
Methotrexate
Adalimumab
RTX-GRT7039

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 17 total trials

A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD)

The primary objective of this study is to evaluate the long-term safety and tolerability of litifilimab in participants with active systemic lupus er...

Invitation-only
Systemic Lupus Erythematosus (SLE)
Drug: Litifilimab-matching placebo
Drug: Litifilimab

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). T...

Enrolling
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Litifilimab

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections...

Active, not recruiting
Osteoarthritis
Drug: RTX-GRT7039
Drug: Placebo

Trial sponsors

Pfizer logo
Amgen logo
Biogen logo
I
R-Pharm logo
Bristol-Myers Squibb (BMS) logo
G
Menarini logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems